These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20338639)

  • 21. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
    Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
    Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.
    Ito T; Yang M; Wang YH; Lande R; Gregorio J; Perng OA; Qin XF; Liu YJ; Gilliet M
    J Exp Med; 2007 Jan; 204(1):105-15. PubMed ID: 17200410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of TRAIL-induced apoptosis in leukemic plasmacytoid dendritic cells.
    Blum A; Chaperot L; Molens JP; Foissaud V; Plantaz D; Plumas J
    Exp Hematol; 2006 Dec; 34(12):1655-62. PubMed ID: 17157162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral blood manipulation significantly affects the result of dendritic cell monitoring.
    Gerrits JH; Athanassopoulos P; Vaessen LM; Klepper M; Weimar W; van Besouw NM
    Transpl Immunol; 2007 Apr; 17(3):169-77. PubMed ID: 17331843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis.
    Novak N; Allam JP; Hagemann T; Jenneck C; Laffer S; Valenta R; Kochan J; Bieber T
    J Allergy Clin Immunol; 2004 Aug; 114(2):364-70. PubMed ID: 15316517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
    Xiao W; Chan A; Waarts MR; Mishra T; Liu Y; Cai SF; Yao J; Gao Q; Bowman RL; Koche RP; Csete IS; DelGaudio NL; Derkach A; Baik J; Yanis S; Famulare CA; Patel M; Arcila ME; Stahl M; Rampal RK; Tallman MS; Zhang Y; Dogan A; Goldberg AD; Roshal M; Levine RL
    Blood; 2021 Mar; 137(10):1377-1391. PubMed ID: 32871587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic HLA mismatched/ haploidentical hematopoietic stem cell transplantation].
    Wu JY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):73-7. PubMed ID: 17650664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recruitment of myeloid and plasmacytoid dendritic cells in cervical mucosa during Chlamydia trachomatis infection.
    Agrawal T; Vats V; Wallace PK; Singh A; Salhan S; Mittal A
    Clin Microbiol Infect; 2009 Jan; 15(1):50-9. PubMed ID: 19046168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells.
    Teleshova N; Jones J; Kenney J; Purcell J; Bohm R; Gettie A; Pope M
    J Leukoc Biol; 2004 Jun; 75(6):1102-10. PubMed ID: 15075365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered maturation of circulating dendritic cells in primary progressive MS patients.
    López C; Comabella M; Al-zayat H; Tintoré M; Montalban X
    J Neuroimmunol; 2006 Jun; 175(1-2):183-91. PubMed ID: 16698091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients.
    Lebre MC; van Capel TM; Bos JD; Knol EF; Kapsenberg ML; de Jong EC
    J Allergy Clin Immunol; 2008 Nov; 122(5):969-976.e5. PubMed ID: 18845325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
    Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
    Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
    Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
    J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-mediated endocytosis of particles by peripheral dendritic cells.
    Andersson LI; Hellman P; Eriksson H
    Hum Immunol; 2008 Oct; 69(10):625-33. PubMed ID: 18703103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Derivation of leukemic plasmacytoid dendritic cells coexpressing a progenitor cell surface antigen, CD117, without interferon-alpha production.
    Takeda T; Hayashida M; Kadowaki N; Takeoka K; Fukuda M; Sakurai Y
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):91-8. PubMed ID: 17891925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.
    van der Molen RG; Sprengers D; Binda RS; de Jong EC; Niesters HG; Kusters JG; Kwekkeboom J; Janssen HL
    Hepatology; 2004 Sep; 40(3):738-46. PubMed ID: 15349914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease.
    Wertheimer AM; Bakke A; Rosen HR
    Hepatology; 2004 Aug; 40(2):335-45. PubMed ID: 15368438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes.
    Duperrier K; Velten FW; Bohlender J; Demory A; Metharom P; Goerdt S
    Mol Immunol; 2005 Aug; 42(12):1531-40. PubMed ID: 15950746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A subset of myeloid dendritic cells derived from peripheral blood monocytes represented a predominant subset characterized by their potential tumor-inhibiting activity.
    Wang M; Shi J; Wan Y; Li J; Yuan Y
    In Vitro Cell Dev Biol Anim; 2009; 45(7):398-404. PubMed ID: 19288161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.